Details for New Drug Application (NDA): 204841
✉ Email this page to a colleague
The generic ingredient in SUMATRIPTAN is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 204841
Tradename: | SUMATRIPTAN |
Applicant: | Lannett Co Inc |
Ingredient: | sumatriptan |
Patents: | 0 |
Pharmacology for NDA: 204841
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 204841
Suppliers and Packaging for NDA: 204841
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUMATRIPTAN | sumatriptan | SPRAY;NASAL | 204841 | ANDA | Lannett Company, Inc. | 0527-1818 | 0527-1818-43 | 6 BLISTER PACK in 1 CARTON (0527-1818-43) / .1 mL in 1 BLISTER PACK |
SUMATRIPTAN | sumatriptan | SPRAY;NASAL | 204841 | ANDA | Lannett Company, Inc. | 0527-1859 | 0527-1859-43 | 6 BLISTER PACK in 1 CARTON (0527-1859-43) / .1 mL in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;NASAL | Strength | 5MG/SPRAY | ||||
Approval Date: | Feb 19, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;NASAL | Strength | 20MG/SPRAY | ||||
Approval Date: | Feb 19, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription